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CD200 (OX-2) is a transmembrane glycoprotein that transmits an immunoregulatory signal through the CD200
receptor (CD200R) to attenuate inﬂammatory reactions and promote immune tolerance. CD200 expression in the
skin has not been described previously. We now report that freshly isolated cells of the murine epidermis contain
a subpopulation of major histocompatibility complex (MHC) class II-negative, CD3-negative keratinocytes that are
CD200-positive. CD200 expression was accentuated in keratinocytes comprising the outer root sheath of the
murine hair follicle (HF). When syngeneic skin grafts were exchanged between gender-matched wild-type (WT) and
CD200-deﬁcient C57BL/6 mice, significant perifollicular and intrafollicular inﬂammation was observed, eventually
leading to the destruction of virtually all HF (alopecia) without significant loss of the CD200-negative grafts. Min-
imal and transient inﬂammation was observed in WT grafts, which persisted long term with hair. There was a 2-fold
increase in graft-inﬁltrating T cells in CD200-deﬁcient skin at 14 d. Alopecia and skin lesions were induced in
CD200-deﬁcient hosts by adoptive transfer of splenocytes from WT mice previously grafted with CD200-negative
skin, but not from mice grafted with WT skin. Collectively, these results suggest that the expression of CD200 in
follicular epithelium attenuates inﬂammatory reactions and may play a role in maintaining immune tolerance to HF-
associated autoantigens.
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CD200, formerly known as OX-2, is a type-1 transmem-
brane glycoprotein expressed in a variety of tissues includ-
ing the thymus, nervous system, vascular endothelium,
trophoblast, ovary, and various cells of the immune system
(Bukovsky et al, 1983; Barclay et al, 1986; Barclay et al,
2002; Clark et al, 2003). CD200 mediates an immunoreg-
ulatory signal by binding to its receptor (CD200R), which is
expressed on cells of the myeloid lineage as well as CD4þ
and gd T cells (Gorczynsky et al, 2000; Wright et al, 2000,
2003). CD200–CD200R interactions attenuate inflammatory
reactions and promote immune tolerance in multiple set-
tings. It is thought that CD200þ cells bind to CD200Rþ
macrophages and granulocytes, downregulating their basal
level of activation and thus restricting their ability to initiate
tissue-specific autoimmunity (Barclay et al, 2002). Consist-
ent with this, CD200-deficient mice (CD200/) have in-
creased numbers of activated CD200Rþ macrophages in
the steady state, chronic central nervous system (CNS) in-
flammation and an exaggerated inflammatory response to
trauma (Hoek et al, 2000). In addition, these mice have an
increased susceptibility to develop experimental autoim-
mune uveoretinitis, experimental allergic encephalomyelitis
and collagen-induced arthritis (Hoek et al, 2000; Broderick
et al, 2002; Gorczynski et al, 2002). Abnormalities in the skin
of CD200/ mice have not been reported previously.
We recently reported that CD200/ mice were resistant
to UV-mediated induction of tolerance to hapten in a murine
contact hypersensitivity model (Rosenblum et al, 2004).
Since CD200 expression in the skin has not been described
previously, we set out to determine which skin-resident cells
expressed CD200 and whether CD200 plays a role in down-
regulating cutaneous immune reactions. We now provide the
first evidence for expression of CD200 in the skin. We show,
as expected, that some Langerhans cells (LC) express
CD200, but we also report that a subset of CD3neg, major
histocompatibility complex (MHC) IIneg epidermal cells (EC)
express CD200 on their cell-surface. These CD200þ EC co-
localized with cytokeratin-14þ (K14þ ) keratinocytes (KC) in
the outer root sheath (ORS) of the murine hair follicle (HF). We
subsequently found that syngeneic, gender-matched skin
grafts lacking CD200 show inflammatory destruction of their
HF (i.e., alopecia), characterized by heightened recruitment
of CD4þ and CD8þ Tcells into the grafts. Alopecia (and skin
lesions) was induced in CD200-deficient hosts by adoptive
transfer of splenocytes from syngeneic wild-type (WT;
CD200þ /þ ) mice previously grafted with CD200/ skin,
but not from those grafted with WT skin, suggesting a cell-
mediated autoimmune etiology.
Abbreviations: a-MSH, a-melanocyte stimulating hormone; ACTH,
adrenocorticotropic; APC, antigen-presenting cells; B6, C57BL/6;
BMC, bone marrow chimeras; CD200R, CD200 receptor; DC,
dendritic cell; EC, epidermal cell; HF, hair follicle; K14, cytokeratin-
14; KC, keratinocyte; LC, Langerhans cell; ORS, outer root sheath;
SFM, serum-free medium; TGF-b, transforming growth factor-b;
WT, wild-type (CD200þ /þ )
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Results
KC express CD200 To determine whether murine EC ex-
pressed CD200 on their cell surface, we performed four-
color flow cytometry on freshly isolated EC obtained from
adult ear skin. We examined CD200 expression on three
major EC populations: T cells (CD3þ , MHC IIneg), LC
(CD3neg, MHC IIþ ) and keratinocytes (KC; CD3neg, MHC
IIneg). As shown in Fig 1a, epidermal T cells did not express
CD200 (‘‘R2’’). Some LCs expressed low levels of CD200
(‘‘R1’’). The percentage of LC in WT and CD200/ mice did
not differ (  2%). We consistently observed a subpopula-
tion of KC (range 5%–15% in adult ear skin) that expressed
high levels of CD200 (Fig 1a) (‘‘R3’’). When EC from murine
pup trunk skin were examined, the percentage of CD200þ
cells was slightly higher (range 15%–25%, not shown).
Subsequently, we tested murine KC cell lines for CD200
expression using flow cytometry and for mRNA using
CD200-specific RT-PCR. For comparison, we also exam-
ined cultures of primary human KC derived from neonatal
foreskins. The murine KC cell lines PAM212 and SP-1 did
not express CD200 (Fig 1b); however, 308 cells, a KC tumor
cell line initiated in vivo with 7, 12-dimethylbenz(a)ant-
hracene (Strickland et al, 1988) expressed high levels of
CD200 (Fig 1b). Although human primary KC did not show
cell surface expression of CD200 (Fig 1b), CD200 mRNA
was detected by RT-PCR (Fig 1c). mRNA from WT and
CD200/ splenocytes were included as positive and neg-
ative controls, respectively.
CD200þ KC localize to HF epithelium To localize
CD200þ cells within the murine epidermis, we performed
both CD200-specific immunohistochemistry and immuno-
fluoresence on whole mounts of murine pup skin. CD200
was primarily localized to HF epithelium (Figs 2 and 3). Ex-
pression of CD200 was relatively uniform throughout the
length of the follicle and was observed surrounding the
bulb, isthmus, bulge, and infundibular regions. Bulb matrix
cells, dermal papillary cells, and the hair shaft did not ex-
press CD200 (Fig 2). K14 is specifically expressed in KC of
the basal layer of the interfollicular epidermis, the ORS and
the outer layer of sebaceous glands (Braun et al, 2003).
Using scanning confocal microscopy, we found that CD200
expression co-localized with the expression of K14 on KC of
the ORS and on interfollicular basal KC (Fig 3). As reported
by others (Clark et al, 1985), CD200 was also expressed on
vascular endothelial cells.
CD200 attenuates HF-associated inﬂammation HF are
considered by some investigators to be sites of immune
privilege (Christoph et al, 2000; Niederkorn, 2003; Paus
et al, 2003). Because CD200–CD200R interactions have
been shown to suppress tissue-specific inflammation in
allografts and in autoimmune disease models (Gorczynski
et al, 2000, 2002; Broderick et al, 2002) and because
CD200/ mice are prone to induction of autoimmune dis-
ease (Hoek et al, 2000), we sought to determine whether
CD200 might affect the fate of skin grafts taken from
CD200/ donors and placed onto CD200þ /þ WT hosts.
Gender-matched (female-to-female) grafts were used to
avoid male (H-Y) antigen-specific rejection. WT-onto-WT
grafts were used as controls. In these studies, we observed
an increased inflammatory cell infiltrate in the dermis of fe-
male CD200/ grafts relative to WT female grafts as early
as 10 d post-transplant (Fig 4a). We observed an increased
inflammatory cell infiltrate in the dermis of female CD200/
grafts relative to WT female grafts as early as 10 d post-
transplant (Fig 4a). The infiltrate consisted of a substantial
mononuclear population and some polymorphonuclear
cells localized primarily in the perifollicular and intrafollicular
regions of HF. By 30–40 d post-grafting, normal HF archi-
tecture in CD200/ grafts was distorted by inflammatory
Figure 1
CD200 expression by freshly isolated murine epider-
mal cells (EC) as well as murine and human keratin-
ocyte (KC) cell lines. (a) EC isolated from either adult
wild-type (WT) or CD200-deficient (CD200/) ear skin
were analyzed for CD3, major histocompatibility complex
(MHC) class II, and CD200 expression by flow cytometry.
All cells shown are viable (7-amino-actinomycin D (7AAD)
negative). Values in upper right quadrant are percent
CD200þ cells. The unusual CD3þ , MHC IIþ cells were
rare (0.1%) and present in both CD200-deficient and WT
EC-suspensions. (b) Primary cultures of human KC (hKC)
and the murine KC cell lines PAM212, SP-1, and 308 were
examined for cell surface CD200 expression by flow
cytometry. Light line, anti-CD200; heavy line, isotype con-
trol. (c) EC derived from neonatal murine trunk skin and
newborn human foreskins were cultured in KC-defined
media. After two passages, mRNA was isolated and
CD200-specific RT-PCR was performed. As control, RT-
PCR was also performed on splenocyte mRNA isolated
from either WT or CD200-deficient (CD200/) B6 mice.
mKC, murine KC; hKC, human KC.
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cells, accompanied by intrafollicular edema and in-
trafollicular apoptotic cells (Fig 4a inset). Inflammatory cells
were rarely observed in the interfollicular dermis and
non-HF associated epidermis. WT grafts showed transient
inflammation and infiltration by mononuclear cells early
post-transplant (e.g., 10–14 d). This was interfollicular and
resolved entirely by 40 d.
Figure4
CD200 expression attenuates hair follicle (HF)-associated inflam-
mation. Tail skin from either wild-type (WT) or CD200-deficient
(CD200/) female B6 mice were grafted onto the trunks of WT fe-
male B6 recipients. (a) At various times post-grafting, punch biopsies
were performed and sections were stained with H&E. Inset represents
higher magnification of boxed area. Arrowheads denote HF. (b) Pho-
tograph of representative grafts at 80 d post-transplant. Results are
representative of five replicate experiments. d, day. Actuarial graft sur-
vival curves are shown in supplemental Fig S1; the differences are not
statistically significant (78% vs 100% 100-d survival for CD200/ and
WT grafts respectively; p40.05).
Figure 2
Cutaneous CD200 expression localizes to hair follicle (HF) epithe-
lium. Neonatal trunk skin was isolated from either wild-type (WT) or
CD200-deficient (CD200/) mice. CD200-specific immunohistochem-
istry was performed on frozen sections as described in Materials and
Methods. Scale; 1 cm¼80 mm (a,b) or 20 mm (c,d). Arrow indicates
CD200þ outer root sheath (ORS). Staining with isotype control IgG is
shown in supplemental Fig S3.
Figure3
CD200 expression co-localizes with K14 on basal keratinocytes
(KC) and KC of the follicular outer root sheath (ORS). Neonatal trunk
skin was isolated from either wild-type (WT) or CD200-deficient
(CD200/) mice. CD200- and K14-specific immunofluorescence was
performed on frozen sections. Images shown are z-projections ob-
tained by sequential scanning confocal microscopy under identical
optical conditions. Arrows denote the epidermis. Scale: 1 cm¼ 40 mm
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Beyond 30–40 d, the hair on all CD200/ female grafts
was completely lost, whereas the skin grafts remained in-
tact (18 of 20 over five independent experiments) (Fig 4b).
Histological examination confirmed loss of HF structures
(Fig 4a). In some CD200/ grafts, dermal inflammation re-
solved after HF loss leaving behind scarring (Fig 4a). In
those grafts, non-HF-associated epidermis remained large-
ly unaffected and hairless grafts persisted long-term (4100
d). No new hair growth was observed. In contrast to the
CD200-deficient grafts, no hair loss was observed in WT
female-to-female grafts (n¼19), and all WT grafts followed
for 4100 d persisted with hair. Two of 20 CD200/ grafts
were lost at 27 and 42 d; three other grafts were lost at 6,
23, and 53 d after being biopsied. No WT-onto-WT grafts
were lost, even after biopsy. The actuarial 100-d survival
rate for CD200/ grafts was not statistically different from
that of WT grafts (78% vs 100%, respectively; p40.05;
supplemental Fig S1).
We next grafted gender-matched WT skin and CD200/
skin onto a small number of CD200/ hosts (three each) to
determine whether the nature of the host (WT vs CD200/)
altered the fate of the graft. As with WT recipients, WT grafts
were accepted by CD200/ hosts (4100 d) with no gross
evidence of hair loss, whereas all three of the CD200/
grafts developed alopecia. Notably, alopecia was confined
to the grafted CD200/ skin and did not spread to involve
intact skin of the CD200/ hosts suggesting a graft-local-
ized effect and, possibly, other mechanisms that protect
CD200/ HF outside the graft.
Phenotype of graft-inﬁltrating T cells To define the phe-
notype of graft-infiltrating T cells, we collected pairs of WT
and CD200/ skin grafts from the same WT hosts at 14 d
after grafting, collagenase digested the skin, and stained
the pooled graft-cell suspensions for CD4 and CD8 Tcells in
the presence of 7-amino-actinomycin D (7AAD) to exclude
dead cells. The results are shown in Fig 5. Both CD4 (2.7%)
and CD8 (8.7%) T cells were detected in the CD200/
grafts; the CD4:CD8 ratio was 1:3. The T cells appeared to
be lymphoblasts based on increased forward light scatter
(supplemental Fig S2). The percentage of T cells (11.4%) in
CD200/ grafts was almost double that of the paired WT
grafts taken from the same mice (6.0%¼ 1.4% CD4 and
4.6% CD8).
Adoptive transfer of alopecia to CD200-deﬁcient hos-
ts Next we sought to determine whether alopecia could be
induced in the skin of CD200-deficient B6 mice. Unsepa-
rated splenocytes from ‘‘HF-sensitized’’ mice (i.e., WT mice
grafted with CD200/ skin43 mo earlier) were mixed with
normal WT bone marrow and given to irradiated CD200-
deficient mice. Creation of bone marrow chimeras (BMC)
ensured engraftment of the infused WTspleen cells. Control
Figure 5
Graft-infiltrating T cells in CD200/ and wild-type (WT) skin grafts
at 14 d. Skin cell suspensions from pairs of WT and CD200/ skin
grafts on WT hosts were collected and pooled for staining with CD4
and CD8-specific antibodies. Gating strategies were based on forward
and side light scatter and exclusion of 7-amino-actinomycin D (7AAD)
as shown in supplemental Fig S2.
Figure 6
Examples of skin and hair lesions in-
duced in autologous bone marrow
chimeras (BMC) (CD200/mice recon-
stituted with wild-type (WT) BM) by
adoptive transfer of HF-sensitized
spleen cells. (a) Ventral surface of BMC
showing alopecia. (b) Close-up view of
abdominal lesions (from panel ‘‘a’’). (c)
Dorsal lesion from another BMC. (d) Phys-
ical damage to scruff of neck of BMC
caused by routine handling. Note the
loose hair and exposed dermis. (e, f )
H&E stains of biopsy sections from typical
lesions. Findings in ‘‘e’’ correspond to
light microscopy studies of the lesion
shown in ‘‘b’’. Skin and hair of BMC giv-
en spleen cells from naı¨ve donors (WT
mice grafted with WT skin) was normal
(not shown).
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BMC received spleen cells from WT donors that had been
grafted earlier with WT skin. Beginning approximately 2 wk
post-transplant, we observed patches of alopecia in BMC
given HF-sensitized syngeneic splenocytes (Fig 6), but not
those given cells from naı¨ve donors. In comparison to re-
cipients of naı¨ve cells, hair was more easily removed from
affected CD200/ mice by gentle plucking. In an extreme
case, the epidermis separated from the dermis in a small
patch on the scruff of the neck as the mouse was being
examined (shown in Fig 6d). Mononuclear infiltrates were
noted in histological examination (Fig 6e and f ), but
their nature has yet to be determined. These lesions
were variable in their severity and did not spread beyond
initial boundaries. With time, hair growth resumed in affect-
ed areas.
Discussion
Our interest in CD200 expression in the skin was prompted
by the observation that cutaneous UVB-mediated tolerance
to hapten could not be induced in mice that were deficient
in CD200 (Rosenblum et al, 2004). As a prelude to studies
on the mechanism involved, we looked at CD200 expres-
sion in murine skin. As expected, a portion of the LC pop-
ulation expressed CD200, but there also was a previously
unidentified subpopulation of CD3neg, MHC IIneg EC that
expressed cell-surface CD200 (Fig 1). Most of these
CD200þ EC co-localized with K14þ KC in the ORS
(Fig 3). In the absence of CD200, we observed heightened
intrafollicular and perifollicular inflammation upon graft-
ing of gender-matched skin from CD200/ donors onto
syngeneic WT hosts (Fig 4), including a doubling in the
number of graft-infiltrating T cells (Fig 5). This eventually led
to complete and permanent hair loss (Fig 4), but not loss of
most CD200/ grafts (supplemental Fig S1). In contrast,
WT grafts remained intact with continued hair growth de-
spite evidence of early T cell infiltration (Fig 5).
Given the extensive literature implicating the CD200–
CD200R pathway in immune tolerance and the fact that the
HF is regarded by many as a site of immune privilege, these
findings are of significant interest.
Mammalian HF are evolutionarily conserved structures
which play a major role in many important biological proc-
esses such as thermal protection, camouflage, tactile sen-
sation, and mating behavior. Since epidermal stem cells
reside in HF, follicular units may play an important role in the
regenerative capacity of the epidermis (Niederkorn, 2003;
Tumbar et al, 2004). It has been proposed that the HF is
distinct sites of immune privilege with a heightened level of
protection from potentially damaging cutaneous inflamma-
tory immune reactions (Paus et al, 2003). Several lines of
evidence support this view: (i) Anagen stage HF have ab-
sent or a very low level of MHC class I expression (Harrist
et al, 1983; Christoph et al, 2000); (ii) anagen hair bulbs
express immunosuppressive factors, such as TGF-b, ACTH,
and a-MSH (Welker et al, 1997; Slominski et al, 1998;
Botchkarev et al, 1999); (iii) anagen hair bulbs have a mark-
edly reduced number of antigen-presenting cells (APC)
which do not appear to express MHC class II (Christoph
et al, 2000); and (iv) HF epithelium express non-classical
MHC class I molecules (Paus et al, 1994) that promote im-
mune tolerance (Fuzzi et al, 2002). Follicles in anagen phase
have the potential to manufacture follicle-associated pro-
teins capable of acting as autoantigens in eliciting HF-di-
rected autoimmunity, such as that observed in alopecia
areata, lupus erythematosus, morphea, lichen planopilaris,
and even graft-versus-host disease (Paus et al, 2003).
The mechanism of destruction of HF in our model using
CD200/ skin grafts is not yet known. CD200 interacts di-
rectly with the CD200R on macrophages and granulocytes,
suppressing their tonic activation and sparing CD200þ tis-
sues from the damaging effects of these cells (Nathan and
Muller, 2001; Barclay et al, 2002). The transient ischemia
and surgical trauma associated with skin grafting are known
to induce a pro-inflammatory environment within the skin
graft as well as the host. In our model, tissue trauma may
incite inflammatory alopecia that fails to resolve in the ab-
sence of CD200. This is consistent with the data from others
showing that inflammation is not appropriately resolved in
the peripheral nervous system of CD200/ mice after trau-
ma from facial nerve transection, resulting in the persistence
of inflammatory cells and increased local tissue damage
(Hoek et al, 2000). Mast cells are among the earliest cells
that respond to tissue injury. They rapidly release pro-in-
flammatory mediators (Sherman, 2001) and are likely can-
didates for initiation of an inflammatory cascade in our skin
graft model. The prominent expression of CD200R on mast
cells led Wright et al (2003) to suggest that the CD200-
CD200R pathway may function as a constitutive regulator of
mast cell biological responses and predispose CD200/
mice to autoimmune diseases. Direct involvement of skin-
resident mast cells in our model, however, remains to be
demonstrated.
CD200þ KC or LC (or both populations) may actively
protect the HF of WT skin grafts by limiting inflammatory
damage. Failure to regulate inflammatory cells within the
graft may lead to the enhanced recruitment of autoreactive
T cells or, alternatively, a failure to recruit regulatory T cells.
Gorczynski et al (2004) recently found that ligation of
CD200R on dendritic cells converts them to a tolerogenic
phenotype that leads to the activation of CD4þ CD25þ
regulatory T cells in vitro. Since some T cells (CD4þ as well
as gdþ T cells) express CD200R (Gorczynsky et al, 2000;
Wright et al, 2000, 2003), it is conceivable that CD200þ KC
or LC cells may interact directly with them. Borriello et al
(1997) originally identified CD200 (OX-2) as a T cell co-
stimulatory molecule, suggesting it as a member of the B7
family. We found that production of pro-inflammatory
cytokines by autoreactive T cells in vitro is diminished in
the presence of autologous DC that express CD200þ
(Rosenblum et al, 2004). Furthermore, we found that soluble
CD200 (in the form of a CD200.FLAG fusion protein) altered
the cytokine gene expression profile of murine CD4þ Tcells
(M.D. Rosenblum, unpublished data).
Spontaneous alopecia, including a scarring alopecia
similar to human follicular degeneration syndrome, has
been reported in some C57BL/6 sublines.1 Abnormalities in
1Sundberg JP, Lorch G, Taylor D, et al: Spontaneous alopecia
and ulcerative dermatitis in C57BL/6J laboratory mice. J Invest
Dermatol 122:A104, 2004 (abstr).
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the skin or hair of CD200/ mice have not been reported
previously. We have not been successful at triggering
hair loss in intact CD200/ mice using skin irritants or
cytokines, although we have not tried combinations such as
the mixture of interferon (IFN)-g, tumor necrosis factor
(TNF)-a, and interleukin (IL)-1b used by Ruckert et al (2000).
Other regulatory mechanisms may be involved in the control
of autoreactive T cells in CD200/ mice. The finding that
lesions induced by adoptive transfer of HF-sensitized
splenocytes did not spread beyond the initial affected ar-
eas indirectly supports this, as does the fact that hair loss in
CD200/ skin grafts placed on CD200/ hosts was con-
fined to the graft and did not involve the adjacent CD200-
deficient skin.
Deficiencies in regulatory mechanisms, including regu-
latory Tcells, have been linked to some forms of alopecia: (i)
McElwee and Hoffmann (2002) report an increase in ex-
pression of regulatory cytokines and suggest failure to re-
cruit CD4 and CD8 T cells as a mechanism of resistance to
alopecia areata; (ii) Zoller et al (2002) found decreased
numbers of CD4þ CD25þ regulatory T cells in the skin of
C3H/HeJ mice with chronic alopecia areata as well as re-
cipients of affected skin; and (iii) Hequet et al (2004) show
that depletion of CD4þ T cells in autologous bone marrow
chimeras induced a skin disease with clinical and histolog-
ical features of alopecia areata. Lethal total body irradiation,
as used by us in creating autologous BMC, is known to
transiently deplete regulatory T cells. New regulatory T cells
are produced de novo and emigrate from the repopulated
host thymus after 2–3 wk (Johnson et al, 1999, 2002). This
coincides with the approximate time that we observed
stabilization of the skin lesions after adoptive transfer of HF-
sensitized splenocytes. We plan to test the hypothesis that
re-emergence of regulatory T cells is responsible for limiting
the extent of skin lesions induced by adoptive transfer of
sensitized splenocytes and, perhaps, also in the intact skin
of unmanipulated CD200/ mice.
Collectively, our data suggests that CD200 provides im-
mune protection to murine HF. This finding also has signif-
icant implications for immune recognition of skin cancer.
Basal cell carcinoma and squamous cell carcinoma of the
skin can arise from malignant transformation of epithelial
cells in the HF (Oro and Higgins, 2003). As shown in Fig 1b,
cell surface expression of CD200 was detected on the
murine KC-derived tumor cell line 308, but not on PAM212
or SP-1 cells. Because these murine KC tumor cell lines are
most likely derived from a single tumor cell clone, we spec-
ulate that 308 cells may be derived from a KC that origi-
nated from CD200þ HF epithelium, whereas PAM212 and
SP-1 cells did not. Alternatively, 308 cells may have induced
CD200 expression upon malignant transformation. Specific
expression of CD200 on 308 cells suggests the possibility
that some KC-derived tumors may exploit CD200 expres-
sion as a means to evade tumor immunity. We previously
reported that several tumor lines, including C1498 (a murine
NKT cell leukemia), SCC-7 (a murine squamous cell carci-
noma), and U2OS (a human osteosarcoma), express CD200
either constitutively or upon induction of apoptosis (Rose-
nblum et al, 2004). Others have shown that CD200 is in-
volved in suppressing tumor-specific immune responses
(Gorczynski et al, 2001). Experiments are planned to deter-
mine whether CD200 alters the immune response to skin
cancer cells, as it appears to do with HF.
Based on the well-documented role for CD200–CD200R
interaction in tolerance induction and the data presented
herein, we propose that CD200 expression on HF epithe-
lium (or LC) directly regulates innate and/or adaptive im-
mune reactions in suppressing HF-associated inflammation
and, perhaps, plays a role in maintaining HF-specific im-
mune tolerance. Whether cells within human hair follicles
express CD200 remains to be determined. Primary human
KC cultures (neonatal foreskin) expressed CD200 mRNA,
but cell surface expression was not observed (Fig 1b, c).
CD200 may be restricted to cells that localize to HF or basal
epidermis in situ. Alternatively, CD200neg KC may preferen-
tially expand upon culture in vitro.
Materials and Methods
Mice C57BL/6 mice (B6) were purchased from Jackson Labora-
tories (Bar Harbor, Maine). CD200/ mice (Hoek et al, 2000) were
provided by Dr Jonathan Sedgwick (DNAX Research Institute, Palo
Alto, California). Age-/sex-matched mice were used in all exper-
iments. All animal experiments were done under protocols ap-
proved by the institutional animal care and use committee.
KC isolation and cell culture The murine KC cell lines, PAM212,
SP-1, and 308 were kindly provided by the laboratory of Dr Stuart
Yuspa (National Cancer Institute, NIH, Bethesda, Maryland). Cell
lines were cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM) (Gibco BRL, Grand Island, New York) supplemented with
10% fetal bovine serum (FBS). Human KC were derived from
newborn human foreskins and cultured in KC-defined serum-free
medium (SFM; Gibco BRL) (Rheinwald and Green, 1975). Neonatal
trunk or adult ear skin was excised from B6 mice and EC were
isolated as previously described (Tamaki et al, 1979). Briefly, skin
was separated from the cartilage plate and floated on 0.5% trypsin
(Gibco BRL) in phosphate-buffered saline (PBS) at 371C for 45min.
Epidermal sheets were peeled from the dermis, re-suspended in
0.05% DNAase (Sigma, St Louis, Missouri) in PBS containing 10%
FBS. Single-cell suspension was obtained by vigorous passage
through a 60 cm3 syringe. For RT-PCR analysis, cells were cultured
in KC-defined SFM. For flow cytometry, freshly isolated murine and
human EC were washed 1  in cold PBS and 4  105 cells were
stained for 30 min at 41C with the following: Alexa Fluor-647
(Molecular Probes, Eugene, Oregon) conjugated rat anti-mCD200
antibody (OX-90), Alexa Fluor-647 conjugated rat IgG isotype con-
trol (R35-95), PE anti-hCD200 (MRC OX-104); FITC anti-I-Ab
(KH74); PE anti-CD3 (145-2C11), and 7AAD (CalBiochem, La Jolla,
California). All antibodies were from Pharmingen (San Diego, Cal-
ifornia). OX-90 and R35-95 mAbs were conjugated to Alexa Fluor
647 according to manufacturer’s protocol. Cells were washed
twice in cold PBS and analyzed by flow cytometry on a Becton
Dickenson (San Jose, California) FACScan flow cytometer.
RT-PCR Mouse and human KC were isolated as described above
and cultured in KC-defined SFM. After two passages, cells were
harvested, and total RNA was extracted with TRIzol according
to manufacturer’s instructions (Life Technologies, Rockville, Mary-
land). RNA was quantified, and equal amounts (1 mg) were
reverse transcribed into cDNA with oligo(dT) primers using
Thermoscript RT-PCR systems (Gibco BRL) according to manu-
facturer’s instructions. RT-PCR was performed using CD200 (50-
AGTGGTGACCCAGGATGAA-30 50-TACTATGGGCTGTACATAG-30)
or b-actin (50-GAGTCCTGTGGCATCCACG-30 50-CTAGGAGCAT-
TTGCGGTG-GAC-30) primer sets.
Immunoﬂuorescence microscopy, immunohistochemistry,
and ﬂow cytometry Neonatal trunk skin was isolated from either
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WT (CD200þ /þ ) or CD200/ mice. Specimens were immediately
placed in Tissue-Tek OCT Compound (Miles, Elkhart, Indiana),
frozen on dry ice, and stored at 701C. 6 mm cryosections
were stained for immunofluorescence microscopy as previously
described (Basset-Seguin et al, 1988). Rat anti-mCD200 (OX-90),
rabbit anti-K14 (AF64; Covance Research, Berkeley, California) or
rat IgG isotype control (R35-95) were used as primary antibodies;
FITC-conjugated goat F(ab)2 anti-rat IgG (Jackson Immunore-
search Laboratories, West Grove, Pennsylvania) and rhodamine-
conjugated goat anti-rabbit IgG (Pierce Biotechnology, Rockford,
Illinois) were used for detection. All antibodies were used at a
1:1000 dilution. Confocal images were acquired using a Leica TCS
SP2 microscope (Leica, Heidelberg, Germany). Approximately 20
optical sections were sequentially captured with a typical incre-
ment of 1–3 mm. Scans are presented as z-projections.
Immunohistochemistry was carried out on frozen sections as
previously described (Homey et al, 2000). Anti-mCD200 mAb or rat
IgG isotype control mAb binding was detected using biotinylated
rabbit anti-rat IgG (Vector Laboratories, Burlingame, California)
followed by streptavidin-peroxidase (Vectastain ABC kit, Vector)
according to manufacturer’s instructions. Peroxidase activity was
revealed using 3, 30-diaminobenzidine substrate (SK-4100, Vector)
for 5–10 min at room temperature. Sections were counterstained
with hematoxylin and eosin (H&E). Isotype control staining is
shown in supplemental Fig S3.
Paired, gender-matched skin grafts from WT and CD200/
were harvested 14 d after grafting onto WT recipients, finely
minced using scissors and digested with collagenase D (1 mg per
mL) for 90 min at 371C. The grafts were disrupted by rapid trit-
uration using a 5 cm3 syringe, pooled, filtered to remove debris,
counted, and then stained with CD4- and CD8-specific antibodies
for analysis by flow cytometery. 7AAD was used to exclude dead
cells. Electronic gates were set on viable cells with forward- and
side-scatter of light characteristic of lymphocytes and lympho-
blasts as shown in supplemental Fig S2).
Skin grafting Tail skin was grafted to the dorsal trunk as previ-
ously described (Rosenberg, 1994). Briefly, tail skin was harvested
from age-matched WT and CD200/ female B6 mice and grafted
onto the backs of age-matched WT B6 females. In some exper-
iments, WTand CD200/ skin was grafted onto alternate flanks on
the same recipient, and in other experiments, each recipient re-
ceived only one graft. Skin grafts were observed daily. Loss of
graft was defined as the day that the grafted skin was no longer
measurable. At various times post-grafting, punch biopsies were
taken from viable grafts. Specimens were fixed in 4% fomalin in
PBS, embedded in paraffin, sectioned at 5 mm thickness, and
stained with H&E. Actuarial graft survival curves were generated
using the pooled results of five experiments, including 19 WT-onto-
WT and 20 CD200/-onto-WT gender-matched grafts. Graft
survival curves were compared by log rank analysis. Skin grafts
that were biopsied were censored from the analysis on the day
of biopsy.
Autologous bone marrow chimeras (BMC) Autologous BMC
were created by lethal irradiation (1100 cGy) of CD200/ B6 mice
1 d before intravenous injection of marrow cells from autologous
WT CD200þþ B6 donors. BM (1  107) was admixed with spleen
cells (2  107) from WT mice grafted4100 d earlier with skin from
either (a) CD200/ (‘‘HF-sensitized’’) or (b) WT (control) donors.
Irradiated CD200/ mice not given BM cells (n¼ 3) died from ra-
diation-induced aplasia at 8, 10, and 13 d.
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Figure S1
Actuarial graft-survival curves, CD200-11-(squares; n¼20) and wild-
type (WT) (triangles; n¼19) B6 skin was grafted onto individual WT
recipients. Grafts were censored from the analysis on the day that they
were biopsied to avoid skewing the outcome since the process ap-
peared to trigger rejection in a few CD200/ grafts but not in any of the
WT grafts.
Figure S2
Gating strategy used for flow cytometric analysis of CD4 and CD8 T
cells in wild-type (WT) and CD200-deficient skin grafts. Debris and
dead cells were excluded on the basis of forward light scatter (FSC)
and uptake of 7AAD (‘‘R1’’ in upper left panel). An electronic gate (‘‘R2’’)
was set around lymphocyte and lymphoblastic populations within R1
based on FSC and side scatter (SSC) (upper right panel). Cells falling
within both R1 and R2 were then analyzed for expression of CD4 and
CD8 (as shown in text Figure 5). Unstained cells (negative controls)
from WT and CD200/ mice are shown in the bottom panels.
Figure S3
Isotype control staining for immunohistochemistry of wild-type C57BL/
6 neonatal pup skin (right panel) as compared to the positive control
stained with CD200-specific antibody (left panel). Immunohistochem-
istry was performed on frozen sections as described in Materials and
Methods.
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